Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma

Progress in Lipid Research

Volumn 52, Issue 4, 2013, Pages 562-570

  Elsherbiny, Marwa E ^a   Emara, Marwan ^a,b   Godbout, Roseline ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Zewail City of Science and Technology   (Egypt)

Author keywords

Arachidonic acid; Astrocytoma; Docosahexaenoic acid; Eicosanoids; Fatty acid binding protein; Lipid metabolism; Malignant glioma

Indexed keywords

ARACHIDONIC ACID; CERVONIC ACID; CYTOCHROME P450; CYTOSOLIC PHOSPHOLIPASE A2; DOCOSAHEXAENOIC ACID; FATTY ACID BINDING PROTEIN; ICOSANOID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN SYNTHASE; PROTEIN FABP7; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER INFILTRATION; CANCER INHIBITION; CANCER PROGNOSIS; CELL MIGRATION; CULTURE MEDIUM; DISORDERS OF LIPID METABOLISM; ENZYME METABOLISM; ENZYME SYNTHESIS; GLIOBLASTOMA; GLIOMA CELL; HUMAN; LIPID COMPOSITION; MOLECULAR MECHANICS; NEUROIMAGING; NONHUMAN; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; SIGNAL TRANSDUCTION; TUMOR PROMOTION;

AA; ACTIVATOR PROTEIN; ALA; AP; ARACHIDONIC ACID; ASTROCYTOMA; BRAIN FATTY ACID BINDING PROTEIN; CIS-LINOLEIC ACID; COX; CYCLOOXYGENASES; CYP; CYTOCHROME P450; DGLA; DHA; DIHOMO-GAMMALINOLENIC ACID; DOCOSAHEXAENOIC ACID; EICOSANOIDS; EICOSAPENTAENOIC ACID; EPA; FABP7 (B-FABP); FATTY ACID BINDING PROTEIN; GAMMA-LINOLENIC ACID; GFAP; GLA; GLIAL FIBRILLARY ACIDIC PROTEIN; LA; LDL; LIPID METABOLISM; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN; LOX; MALIGNANT GLIOMA; MAPK; MITOGEN-ACTIVATED PROTEIN KINASE; NFI; NUCLEAR FACTOR I; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PG; PHOSPHOLIPASE A(2); PLA(2); POLYUNSATURATED FATTY ACID; PPAR; PPAR RESPONSE ELEMENT; PPRE; PROSTAGLANDIN; PUFA; VERY LOW DENSITY LIPOPROTEIN; VLDL; Α-LINOLENIC ACID;

ARACHIDONIC ACID; BRAIN NEOPLASMS; DOCOSAHEXAENOIC ACIDS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, UNSATURATED; GLIOMA; HUMANS; PROGNOSIS;

EID: 84883633341     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2013.08.004     Document Type: Review

References (123)

1. P.Y. Wen, and S. Kesari Malignant gliomas in adults N Engl J Med 359 2008 492 507
2. M.C. Chamberlain Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas Cancer 116 2010 3988 3999
3. P.H. Wessels, W.E. Weber, G. Raven, F.C. Ramaekers, A.H. Hopman, and A. Twijnstra Supratentorial grade II astrocytoma: biological features and clinical course Lancet Neurol 2 2003 395 403
4. M. Niyazi, A. Siefert, S.B. Schwarz, U. Ganswindt, F.W. Kreth, and J.C. Tonn Therapeutic options for recurrent malignant glioma Radiother Oncol 98 2011 1 14
5. L.C. Hou, A. Veeravagu, A.R. Hsu, and V.C. Tse Recurrent glioblastoma multiforme: a review of natural history and management options Neurosurg Focus 20 2006 E5
6. F.G. Barker 2nd, S.M. Chang, P.H. Gutin, M.K. Malec, M.W. McDermott, and M.D. Prados Survival and functional status after resection of recurrent glioblastoma multiforme Neurosurgery 42 1998 709 720 discussion 20-3
7. P. Dirks, M. Bernstein, P.J. Muller, and W.S. Tucker The value of reoperation for recurrent glioblastoma Can J Surg 36 1993 271 275
8. E.S. Mandl, C.M. Dirven, D.R. Buis, T.J. Postma, and W.P. Vandertop Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy Surg Neurol 69 2008 506 509 discussion 9
9. R. Mayer, and P. Sminia Reirradiation tolerance of the human brain Int J Radiat Oncol Biol Phys 70 2008 1350 1360
10. L. VanderSpek, B. Fisher, G. Bauman, and D. Macdonald 3D conformal radiotherapy and cisplatin for recurrent malignant glioma Can J Neurol Sci 35 2008 57 64
11. P. Chinnaiyan, E. Kensicki, G. Bloom, A. Prabhu, B. Sarcar, and S. Kahali The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism Cancer Res 72 2012 5878 5888
12. D.D. Martin, M.E. Robbins, A.A. Spector, B.C. Wen, and D.H. Hussey The fatty acid composition of human gliomas differs from that found in nonmalignant brain tissue Lipids 31 1996 1283 1288
13. Y. Liang, M. Diehn, N. Watson, A.W. Bollen, K.D. Aldape, and M.K. Nicholas Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme Proc Natl Acad Sci USA 102 2005 5814 5819
14. C.L. Tso, P. Shintaku, J. Chen, Q. Liu, J. Liu, and Z. Chen Primary glioblastomas express mesenchymal stem-like properties Mol Cancer Res 4 2006 607 619
15. Y. Liang, A.W. Bollen, K.D. Aldape, and N. Gupta Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma BMC Cancer 6 2006 97
16. G. Kaloshi, K. Mokhtari, C. Carpentier, S. Taillibert, J. Lejeune, and Y. Marie FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status J Neurooncol 84 2007 245 248
17. R. Mita, J.E. Coles, D.D. Glubrecht, R. Sung, X. Sun, and R. Godbout B-FABP-expressing radial glial cells: the malignant glioma cell of origin? Neoplasia 9 2007 734 744
18. R. Mita, M.J. Beaulieu, C. Field, and R. Godbout Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration J Biol Chem 285 2010 37005 37015
19. A.C. Guyton, and J.E. Hall Textbook of medical physiology 2006 Elsevier Saunders
20. Y. Owada Fatty acid binding protein: localization and functional significance in the brain Tohoku J Exp Med 214 2008 213 220
21. J.M. Bourre, G. Pascal, G. Durand, M. Masson, O. Dumont, and M. Piciotti Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids J Neurochem 43 1984 342 348
22. C.T. Chen, J.T. Green, S.K. Orr, and R.P. Bazinet Regulation of brain polyunsaturated fatty acid uptake and turnover Prostaglandins Leukot Essent Fatty Acids 79 2008 85 91
23. C.T. Chen, D.W. Ma, J.H. Kim, H.T. Mount, and R.P. Bazinet The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations J Lipid Res 49 2008 147 152
24. T. Rahman, A.Y. Taha, B.J. Song, S.K. Orr, Z. Liu, and C.T. Chen The very low density lipoprotein receptor is not necessary for maintaining brain polyunsaturated fatty acid concentrations Prostaglandins Leukot Essent Fatty Acids 82 2010 141 145
25. R.K. Ockner, and J.A. Manning Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport J Clin Invest 54 1974 326 338
26. B. Rustow, D. Kunze, J. Hodi, and E. Egger A fatty acid binding peptide of rat liver cytosol: characterization and origin FEBS Lett 108 1979 469 472
27. C. Unterberg, G. Heidl, D.B. von Bassewitz, and F. Spener Isolation and characterization of the fatty acid binding protein from human heart J Lipid Res 27 1986 1287 1293
28. R.U. Haq, L. Christodoulides, B. Ketterer, and E. Shrago Characterization and purification of fatty acid-binding protein in rat and human adipose tissue Biochim Biophys Acta 713 1982 193 198
29. G. Siegenthaler, R. Hotz, D. Chatellard-Gruaz, L. Didierjean, U. Hellman, and J.H. Saurat Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro Biochem J 302 Pt 2 1994 363 371
30. S. Stengelin, S. Apel, W. Becker, M. Maier, J. Rosenberger, and U. Bewersdorf The rabbit ileal lipid-binding protein. Gene cloning and functional expression of the recombinant protein Eur J Biochem 239 1996 887 896
31. F. Shimizu, T.K. Watanabe, H. Shinomiya, Y. Nakamura, and T. Fujiwara Isolation and expression of a cDNA for human brain fatty acid-binding protein (B-FABP) Biochim Biophys Acta 1354 1997 24 28
32. Majava V, Polverini E, Mazzini A, Nanekar R, Knoll W, Peters J, et al. Structural and functional characterization of human peripheral nervous system myelin protein P2. PLoS One 2010;5:e10300.
33. R.Z. Liu, X. Li, and R. Godbout A novel fatty acid-binding protein (FABP) gene resulting from tandem gene duplication in mammals: transcription in rat retina and testis Genomics 92 2008 436 445
34. T. Kido, and H. Namiki Expression of testicular fatty acid-binding protein PERF 15 during germ cell apoptosis Dev Growth Differ 42 2000 359 366
35. U.N. Das Essential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer, and metastasis Cancer Metastasis Rev 30 2011 311 324
36. S.I. Rapoport, J.S. Rao, and M. Igarashi Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver Prostaglandins Leukot Essent Fatty Acids 77 2007 251 261
37. S.I. Rapoport, and M. Igarashi Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA? Prostaglandins Leukot Essent Fatty Acids 81 2009 119 123
38. C.R. Santos, and A. Schulze Lipid metabolism in cancer FEBS J 279 2012 2610 2623
39. T. Nariai, J.J. DeGeorge, N.H. Greig, S. Genka, S.I. Rapoport, and A.D. Purdon Differences in rates of incorporation of intravenously injected radiolabeled fatty acids into phospholipids of intracerebrally implanted tumor and brain in awake rats Clin Exp Metastasis 12 1994 213 225
40. D.H. Albert, and C.E. Anderson Fatty acid composition at the 2-position of ether-linked and diacyl ethanolamine and choline phosphoglycerides of human brain tumors Lipids 12 1977 722 728
41. R. Marszalek, M. Pisklak, W. Jankowski, J. Lukaszkiewicz, D. Horsztynski, and I. Wawer NMR and gas chromatography studies of lyophilized human brain tumors Acta Pol Pharm 67 2010 129 136
42. M. Igarashi, J.C. DeMar Jr., K. Ma, L. Chang, J.M. Bell, and S.I. Rapoport Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation J Lipid Res 48 2007 1150 1158
43. M. Igarashi, K. Ma, L. Chang, J.M. Bell, and S.I. Rapoport Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain J Lipid Res 48 2007 2463 2470
44. M. Igarashi, H.W. Kim, L. Chang, K. Ma, and S.I. Rapoport Dietary n-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain J Neurochem 120 2012 985 997
45. H.W. Kim, J.S. Rao, S.I. Rapoport, and M. Igarashi Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain Biochim Biophys Acta 1811 2011 111 117
46. Y. Denkins, D. Kempf, M. Ferniz, S. Nileshwar, and D. Marchetti Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma J Lipid Res 46 2005 1278 1284
47. R.J. Deckelbaum, T.S. Worgall, and T. Seo N-3 fatty acids and gene expression Am J Clin Nutr 83 2006 1520S 1525S
48. A.B. Venkatachalam, S.P. Lall, E.M. Denovan-Wright, and J.M. Wright Tissue-specific differential induction of duplicated fatty acid-binding protein genes by the peroxisome proliferator, clofibrate, in zebrafish (Danio rerio) BMC Evol Biol 12 2012 112
49. D.Y. Hung, F.J. Burczynski, P. Chang, A. Lewis, P.P. Masci, and G.A. Siebert Fatty acid binding protein is a major determinant of hepatic pharmacokinetics of palmitate and its metabolites Am J Physiol Gastrointest Liver Physiol 284 2003 G423 G433
50. R.Z. Liu, R. Mita, M. Beaulieu, Z. Gao, and R. Godbout Fatty acid binding proteins in brain development and disease Int J Dev Biol 54 2010 1229 1239
51. Y. Owada, T. Yoshimoto, and H. Kondo Spatio-temporally differential expression of genes for three members of fatty acid binding proteins in developing and mature rat brains J Chem Neuroanat 12 1996 113 122
52. E.J. Murphy, Y. Owada, N. Kitanaka, H. Kondo, and J.F. Glatz Brain arachidonic acid incorporation is decreased in heart fatty acid binding protein gene-ablated mice Biochemistry 44 2005 6350 6360
53. T. Hanhoff, C. Lucke, and F. Spener Insights into binding of fatty acids by fatty acid binding proteins Mol Cell Biochem 239 2002 45 54
54. A. Kurtz, A. Zimmer, F. Schnutgen, G. Bruning, F. Spener, and T. Muller The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development Development 120 1994 2637 2649
55. L. Feng, M.E. Hatten, and N. Heintz Brain lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS Neuron 12 1994 895 908
56. G.K. Balendiran, F. Schnutgen, G. Scapin, T. Borchers, N. Xhong, and K. Lim Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein J Biol Chem 275 2000 27045 27054
57. A. De Rosa, S. Pellegatta, M. Rossi, P. Tunici, L. Magnoni, and M.C. Speranza A Radial Glia Gene Marker, Fatty Acid Binding Protein 7 (FABP7), Is Involved in Proliferation and Invasion of Glioblastoma Cells PLoS One 7 2012 e52113
58. O. Cataltepe, M.C. Arikan, E. Ghelfi, C. Karaaslan, Y. Ozsurekci, and K. Dresser Fatty acid binding protein 4 is expressed in distinct endothelial and non-endothelial cell populations in glioblastoma Neuropathol Appl Neurobiol 38 2012 400 410
59. D.A. Bernlohr, N.R. Coe, M.A. Simpson, and A.V. Hertzel Regulation of gene expression in adipose cells by polyunsaturated fatty acids Adv Exp Med Biol 422 1997 145 156
60. C.D. Kane, and D.A. Bernlohr A simple assay for intracellular lipid-binding proteins using displacement of 1-anilinonaphthalene 8-sulfonic acid Anal Biochem 233 1996 197 204
61. K. Fujishiro, Y. Fukui, O. Sato, K. Kawabe, K. Seto, and K. Motojima Analysis of tissue-specific and PPARalpha-dependent induction of FABP gene expression in the mouse liver by an in vivo DNA electroporation method Mol Cell Biochem 239 2002 165 172
62. H.A. Hostetler, A.L. McIntosh, B.P. Atshaves, S.M. Storey, H.R. Payne, and A.B. Kier L-FABP directly interacts with PPARalpha in cultured primary hepatocytes J Lipid Res 50 2009 1663 1675
63. A. Ibabe, A. Herrero, and M.P. Cajaraville Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes Toxicol In Vitro 19 2005 725 735
64. J. Nasrollahzadeh, F. Siassi, M. Doosti, M.R. Eshraghian, F. Shokri, and M.H. Modarressi The influence of feeding linoleic, gamma-linolenic and docosahexaenoic acid rich oils on rat brain tumor fatty acids composition and fatty acid binding protein 7 mRNA expression Lipids Health Dis 7 2008 45
65. M. Brun, J.E. Coles, E.A. Monckton, D.D. Glubrecht, D. Bisgrove, and R. Godbout Nuclear factor I regulates brain fatty acid-binding protein and glial fibrillary acidic protein gene expression in malignant glioma cell lines J Mol Biol 391 2009 282 300
66. R.Z. Liu, E.A. Monckton, and R. Godbout Regulation of the FABP7 gene by PAX6 in malignant glioma cells Biochem Biophys Res Commun 422 2012 482 487
67. Y.H. Zhou, F. Tan, K.R. Hess, and W.K. Yung The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival Clin Cancer Res 9 2003 3369 3375
68. J. Li, Y. Cui, G. Gao, Z. Zhao, H. Zhang, and X. Wang Notch1 is an independent prognostic factor for patients with glioma J Surg Oncol 103 2011 813 817
69. B.W. Purow, R.M. Haque, M.W. Noel, Q. Su, M.J. Burdick, and J. Lee Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation Cancer Res 65 2005 2353 2363
70. T.E. Anthony, H.A. Mason, T. Gridley, G. Fishell, and N. Heintz Brain lipid-binding protein is a direct target of Notch signaling in radial glial cells Genes Dev 19 2005 1028 1033
71. S. Han, H. Inoue, L.C. Flowers, and N. Sidell Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells Clin Cancer Res 9 2003 4627 4635
72. N.Y. Marden, and M. Murray Characterization of a c-Jun-responsive module in the 5'-flank of the human CYP2J2 gene that regulates transactivation Biochem J 391 2005 631 640
73. V.C. Allport, D.M. Slater, R. Newton, and P.R. Bennett NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH) Mol Hum Reprod 6 2000 561 565
74. M.J. LaVoie, and D.J. Selkoe The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signaling fragments J Biol Chem 278 2003 34427 34437
75. S. Chakraborti Phospholipase A(2) isoforms: a perspective Cell Signal 15 2003 637 665
76. J.W. Phillis, L.A. Horrocks, and A.A. Farooqui Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders Brain Res Rev 52 2006 201 243
77. E.A. Dennis, S.G. Rhee, M.M. Billah, and Y.A. Hannun Role of phospholipase in generating lipid second messengers in signal transduction FASEB J 5 1991 2068 2077
78. D.E. Vance, and J.E. Vance Phospholipid biosynthesis in eukaryotes Biochemistry of Lipids, Lipoproteins and Membranes 5th ed. 2008 Elsevier Amsterdam
79. 2+ Br J Pharmacol 139 2003 1014 1022
80. M.V. Winstead, J. Balsinde, and E.A. Dennis Calcium-independent phospholipase A(2): structure and function Biochim Biophys Acta 1488 2000 28 39
81. S.E. Barbour, A. Kapur, and C.L. Deal Regulation of phosphatidylcholine homeostasis by calcium-independent phospholipase A2 Biochim Biophys Acta 1439 1999 77 88
82. C. Arnold, M. Markovic, K. Blossey, G. Wallukat, R. Fischer, and R. Dechend Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids J Biol Chem 285 2010 32720 32733
83. C.N. Serhan Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins Curr Opin Clin Nutr Metab Care 8 2005 115 121
84. Y. Kita, T. Ohto, N. Uozumi, and T. Shimizu Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s Biochim Biophys Acta 1761 2006 1317 1322
85. A. Sapirstein, and J.V. Bonventre Specific physiological roles of cytosolic phospholipase A(2) as defined by gene knockouts Biochim Biophys Acta 1488 2000 139 148
86. J.V. Bonventre, Z. Huang, M.R. Taheri, E. O'Leary, E. Li, and M.A. Moskowitz Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2 Nature 390 1997 622 625
87. M. Ghosh, D.E. Tucker, S.A. Burchett, and C.C. Leslie Properties of the Group IV phospholipase A2 family Prog Lipid Res 45 2006 487 510
88. W.H. Tung, I.T. Lee, H.L. Hsieh, and C.M. Yang EV71 induces COX-2 expression via c-Src/PDGFR/PI3K/Akt/p42/p44 MAPK/AP-1 and NF-kappaB in rat brain astrocytes J Cell Physiol 224 2010 376 386
89. M. Karin The regulation of AP-1 activity by mitogen-activated protein kinases J Biol Chem 270 1995 16483 16486
90. K.G. Leong, and A. Karsan Recent insights into the role of Notch signaling in tumorigenesis Blood 107 2006 2223 2233
91. Rogowski AS. Notch-1 Specifically Activates Erk1/2 in Multiple Breast Cancer Subtypes, Master's Theses. Chicago: Loyola University; 2011.
92. M. Moes, J. Boonstra, and E. Regan-Klapisz Novel role of cPLA(2)alpha in membrane and actin dynamics Cell Mol Life Sci 67 2010 1547 1557
93. R.A. Stockton, and B.S. Jacobson Modulation of cell-substrate adhesion by arachidonic acid: lipoxygenase regulates cell spreading and ERK1/2-inducible cyclooxygenase regulates cell migration in NIH-3T3 fibroblasts Mol Biol Cell 12 2001 1937 1956
94. N. Navarro-Tito, T. Robledo, and E.P. Salazar Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells Exp Cell Res 314 2008 3340 3355
95. S.F. van Helden, D.J. Krooshoop, K.C. Broers, R.A. Raymakers, C.G. Figdor, and F.N. van Leeuwen A critical role for prostaglandin E2 in podosome dissolution and induction of high-speed migration during dendritic cell maturation J Immunol 177 2006 1567 1574
96. T. Tanabe, and N. Tohnai Cyclooxygenase isozymes and their gene structures and expression Prostaglandins Other Lipid Mediat 68-69 2002 95 114
97. A. Nadjar, V. Tridon, M.J. May, S. Ghosh, R. Dantzer, and T. Amedee NFkappaB activates in vivo the synthesis of inducible Cox-2 in the brain J Cereb Blood Flow Metab 25 2005 1047 1059
98. B.S. Min, Y.J. Choi, H.R. Pyo, H. Kim, J. Seong, and H.C. Chung Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer Arch Surg 143 2008 1091 1097 discussion 7
99. K. Muller-Decker, and G. Furstenberger The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis Mol Carcinog 46 2007 705 710
100. A.K. Singh, R. Parshad, S. Pasi, T. Madhavan, S.N. Das, and B. Mishra Prognostic significance of cyclooxygenase-2 and response to chemotherapy in invasive ductal breast carcinoma patients by real time surface plasmon resonance analysis DNA Cell Biol 30 2011 801 807
101. M.J. Fidler, A. Argiris, J.D. Patel, D.H. Johnson, A. Sandler, and V.M. Villaflor The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib Clin Cancer Res 14 2008 2088 2094
102. K. Almhanna, B. El-Rayes, S. Sethi, G. Dyson, L. Heilbrun, and P.A. Philip Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinoma Anticancer Res 32 2012 3559 3563
103. T. Shono, P.J. Tofilon, J.M. Bruner, O. Owolabi, and F.F. Lang Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations Cancer Res 61 2001 4375 4381
104. M. Perdiki, P. Korkolopoulou, I. Thymara, G. Agrogiannis, C. Piperi, and E. Boviatsis Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival Mol Cell Biochem 295 2007 75 83
105. L. Xu, C. Han, and T. Wu A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth J Biol Chem 281 2006 33982 33996
106. D. Panigrahy, A. Kaipainen, E.R. Greene, and S. Huang Cytochrome P450-derived eicosanoids: the neglected pathway in cancer Cancer Metastasis Rev 29 2010 723 735
107. C. Chen, G. Li, W. Liao, J. Wu, L. Liu, and D. Ma Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo J Pharmacol Exp Ther 329 2009 908 918
108. J.G. Jiang, Y.G. Ning, C. Chen, D. Ma, Z.J. Liu, and S. Yang Cytochrome p450 epoxygenase promotes human cancer metastasis Cancer Res 67 2007 6665 6674
109. J.G. Jiang, C.L. Chen, J.W. Card, S. Yang, J.X. Chen, and X.N. Fu Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors Cancer Res 65 2005 4707 4715
110. A.G. Spencer, J.W. Woods, T. Arakawa, I.I. Singer, and W.L. Smith Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy J Biol Chem 273 1998 9886 9893
111. D. Werck-Reichhart, and R. Feyereisen Cytochromes P450: a success story Genome Biol 1 2000 REVIEWS3003
112. T. Itoh, L. Fairall, K. Amin, Y. Inaba, A. Szanto, and B.L. Balint Structural basis for the activation of PPARgamma by oxidized fatty acids Nat Struct Mol Biol 15 2008 924 931
113. A. Adida, and F. Spener Adipocyte-type fatty acid-binding protein as inter-compartmental shuttle for peroxisome proliferator activated receptor gamma agonists in cultured cell Biochim Biophys Acta 1761 2006 172 181
114. I.J. Edwards, and J.T. O'Flaherty Omega-3 Fatty Acids and PPARgamma in Cancer PPAR Res 2008 2008 358052
115. G.H. Rao, E. Radha, and J.G. White Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function Biochem Biophys Res Commun 117 1983 549 555
116. H. Gleissman, R. Yang, K. Martinod, M. Lindskog, C.N. Serhan, and J.I. Johnsen Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates FASEB J 24 2010 906 915
117. C.N. Serhan, S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, and G. Mirick Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J Exp Med 196 2002 1025 1037
118. J. Kalman, A. Gecse, T. Farkas, F. Joo, G. Telegdy, and A. Lajtha Dietary manipulation with high marine fish oil intake of fatty acid composition and arachidonic acid metabolism in rat cerebral microvessels Neurochem Res 17 1992 167 172
119. G. Esposito, G. Giovacchini, M. Der, J.S. Liow, A.K. Bhattacharjee, and K. Ma Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomography Neuroimage 34 2007 1342 1351
120. G. Esposito, G. Giovacchini, J.S. Liow, A.K. Bhattacharjee, D. Greenstein, and M. Schapiro Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET J Nucl Med 49 2008 1414 1421
121. R. Pichika, A.Y. Taha, F. Gao, K. Kotta, Y. Cheon, and L. Chang The synthesis and in vivo pharmacokinetics of fluorinated arachidonic acid: implications for imaging neuroinflammation J Nucl Med 53 2012 1383 1391
122. M. Basselin, E. Ramadan, and S.I. Rapoport Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans Brain Res Bull 87 2011 154 171
123. R.S. Liu, C.P. Chang, L.S. Chu, Y.K. Chu, H.J. Hsieh, and C.W. Chang PET imaging of brain astrocytoma with 1-11C-acetate Eur J Nucl Med Mol Imaging 33 2006 420 427